Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells

Oncotarget

Volumn 7, Issue 28, 2016, Pages 43852-43867

  Burgett, Monica E ^a,b   Lathia, Justin D ^a   Roth, Patrick ^c   Nowacki, Amy S ^a   Galileo, Deni S ^f   Pugacheva, Elena ^d   Huang, Ping ^a   Vasanji, Amit ^e   Li, Meizhang ^a   Byzova, Tatiana ^a   Mikkelsen, Tom ^g   Bao, Shideng ^a   Rich, Jeremy N ^a   Weller, Michael ^c   Gladson, Candece L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e ImageIQ Inc   (United States)

^f HELEN F GRAHAM CANCER CENTER   (United States)

^g HENRY FORD HOSPITAL   (United States)

Author keywords

Angiogenesis; Cancer stem cells; Endothelial cells; Glioblastoma; Integrin v 3

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBROBLAST GROWTH FACTOR; INTEGRIN; INTEGRIN BETAVBETA3; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CELL CONTACT; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PERIVASCULAR SPACE; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR XENOGRAFT; X CHROMOSOME; ANIMAL; CELL MOTION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL MOVEMENT; ENDOTHELIAL CELLS; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; INTEGRIN ALPHAVBETA3; MICE; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 84978741623     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9700     Document Type: Article

References (61)

1. Ahluwalia MS, Gladson CL. Progress on antiangiogenic therapy for patients with malignant glioma. J Oncol 2010; 2010: 689018.
2. Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol 2011; 28:13-24.
3. Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol 2012; 181:1126-41.
4. Folkins C, Shaked Y, Man S, Tang T, Lee CR, Zhu Z, Hoffman RM, Kerbel RS. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 2009; 69:7243-51.
5. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66:7843-8.
6. De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquière B, Cauwenberghs S, Eelen G, Phng LK, Betz I, Tembuyser B, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013; 154:651-663.
7. Ding Q, Stewart JEJr, Olman MA, Klobe MR, Gladson CL. The Pattern of Enhancement of Src Kinase Activity on Platelet-derived Growth Factor Stimulation of Glioblastoma Cells Is Affected by the Integrin Engaged. J Biol Chem 2003; 278:39882-39891.
8. Huttenlocher A, Horwitz AR. Integrins in cell migration. Cold Spring Harb Perspect Biol 2011; 3:a005074.
9. Cheresh DA, Stupack DG. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 2008; 27:6285-98.
10. Guerrero MS, Parsons JT, Bouton AH. Cas and NEDD9 contribute to tumor progression through dynamic regulation of the cytoskeleton. Genes Cancer 2012; 3:371-381. doi: 10.1177/1947601912458585.
11. Ding Q, Stewart JE Jr, Prince CW, Chang P-L, Trikha M, Han X, Grammer JR, Gladson CL. Promotion of Malignant Astrocytoma Cell Migration by Osteopontin Expressed in the Normal Brain: Differences in Integrin Signaling During Cell Adhesion to Osteopontin Versus Vitronectin. Cancer Res, 2002, 62:5336-5343.
12. Natarajan M, Stewart JE Jr, Golemis E, Pugacheva E, Alexandropoulos K, Grammer JR, Gladson CL. HEF1 is a Necessary and Specific Downstream Effector of FAK that Promotes the Migration of Glioblastoma Cells. Oncogene, 2006; 25:1721-1732.
13. Kiefel H, Bondong S, Hazin J, Ridinger J, Schirmer U, Riedle S, Altevogt P. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr 2012; 6:374-84.
14. Montgomery AM, Becker JC, Siu CH, Lemmon VP, Cheresh DA, Pancook JD, Zhao X, Reisfeld RA. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. J Cell Biol 1996; 132:475-85.
15. Chen MM, Lee CY, Leland HA, Lin GY, Montgomery AM, Silletti S. Inside-out regulation of L1 conformation, integrin binding, proteolysis, and concomitant cell migration. Mol Biol Cell 2010; 21:1671-85.
16. Gast D, Riedle S, Kiefel H, Muerkoster SS, Schafer H, Schafer MK, Altevogt P. The RGD integrin binding site in human L1-CAM is important for nuclear signaling. Exp Cell Res 2008; 314:2411-8.
17. Oleszewski M, Beer S, Katich S, Geiger C, Zeller Y, Rauch U, Altevogt P. Integrin and neurocan binding to L1 involves distinct Ig domains. J Biol Chem 1999; 274:24602-10.
18. Anderson, HJ, Galileo DS. Small-molecule inhibitors of FGFR, integrins, and L1CAM selectively decrease L1CAMstimulated glioblastoma cell motility and proliferation. Cell Oncol 2016; Feb 16. [Epub ahead of print].
19. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11:69-82.
20. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, MacSwords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010; 6:421-432.
21. Galan-Moya EM, Le Guelte A, Lima Fernandes E, Thirant C, Dwyer J, Bidere N, Couraud PO, Scott MG, Junier MP, Chneiweiss H, Gavard J. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep 2011; 12:470-6.
22. Charles N, Ozawa T, Squatrito M, Bleau A-M, Brennan CW, Hambardzumyan D, Holland EC. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010; 6:doi:10.1016/j.stem.2010.01.001.
23. Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, Bae E, Selfridge J, Cheng L, et al. Laminin alpha-2 enables glioblastoma stem cell growth. Ann Neurol 2012; 2:766-778.
24. Lugassy C, Wadehra M, Li X, Corselli M, Akhavan D, Binder SW, Péault B, Cochran AJ, Mischel PS, Kleinman HK, Barnhill RL. Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenviron 2013; 6:19-29.
25. Gladson CL. Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 1996; 55:1143-9.
26. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008; 68:6043-8.
27. Silletti S, Mei F, Sheppard D, Montgomery AM. Plasminsensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment. J Cell Biol 2000; 149:1485-502.
28. Mohanan V, Temburni MK, Kappes JC, Galileo DS. L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor. Clin Exp Metastasis 2013; 30:507-520.
29. Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 2009; 76:192-9.
30. Huang P, Rani MR, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AE, Lathia JD, Rich JN, Tipps R, Gladson CL. Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin alpha6beta1 in glioblastoma. Cancer Res 2012; 72:1428-37.
31. Mahabeleshwar GH, Chen J, Feng W, Somanath PR, Razorenova OV, Byzova TV. Integrin affinity modulation in angiogenesis. Cell Cycle 2008; 7:335-47.
32. Somanath PR, Ciocea A, Byzova TV. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys 2009; 53:53-64.
33. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009; 27:40-8.
34. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Science 2004; 117:4619-28.
35. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. The role of myosin II in glioma invasion of the brain. Mol Biol Cell 2008; 19:3357-68.
36. Abassi YA, Rehn M, Ekman N, Alitalo K, Vuori K. p130CAS couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J Biol Chem 2003; 278:35636-35643.
37. Chatterjee S, Matsumura A, Schradermeier J, Gillespie GY. Human malignant glioma therapy using anti-alpha(v)beta(3) integrin agents. J Neurooncol 2000; 46:135-44.
38. Mikkelsen T, Brodie C, Finniss S, Berens ME, Rennert JL, Nelson K, Lemke N, Brown SL, Hahn D, Neuteboom B, Goodman SL. Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency. Int J Cancer 2009; 124:2719-27.
39. He Z, Luo Y, Tang S, Rajantie I, Salven P, Heil M, Zhang R, Luo D, Li X, Chi H, Yu J, Carmeliet P, Schaper W et al. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest 2006; 116:2344-2355.
40. Holopainen T, Lopez-Alpuche V, Zheng W, Heljasvaara R, Jones D, He Y, Tvorogov D, D'Amico G, Wiener Z, Andersson LC, Pihlajaniemi T, Min W, Alitalo K. Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. Cancer Res 2012; 72:3512-21.
41. Nikonova AS, Gaponova AV, Kudinov AE, Golemis EA. CAS proteins in health and disease. IUBMB Life 2014; 66:387-395.
42. Qiu Y, Kung H-J. Signaling network of the Btk family kinases. Oncogene 2000; 19:5651-5661.
43. Takesono A, Finkelstein LD, Schwartzberg PL. Beyond calcium: new signaling pathways for Tec family kinases. J Cell Science 2002; 115:3039-3048.
44. Chen R, Kim O, Li M, Xiong X, Guan J-L, Kung H-J, Chen H, Shimizu Y, Qiu Y. Regulation of the PH-domaincontaining tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat Cell Biol 2001; 3:439-444.
45. Zhang R, Xu Y, Ekmans N, Wu Z, Wu J, Alitalo K, Min W. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J Biol Chem 2003; 278:51267-51276.
46. Chen, S, Jiang X, Gewinner CA, Asara JM, Simon NI, Cai C, Cantley LC, Balk SP. Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases. Science Signal 2013; 6:doi: 10.1126/scisignal.2003936.
47. Nabors LB, Fink KL, Mikkelsen T, Grujicic D, Tarnawski R, Nam do H, Mazurkiewicz M, Salacz M, Ashby L, Zagonel V, Depenni R, Perry JR, Hicking C, et al. Two cilengitide regimens in combination with standard treatment for pateints with newly diagnosed glioblastoma and unmethylated MGMT gene promoter:results of the openlabel, controlled, randomized phase II CORE study. Neuro Oncol 2015; 17:708-717.
48. Friedlander M, Brocks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct av integrins. Science 1995; 270:1500-1502.
49. Hood JD, Frausto R, Kiosses WB, Shwartz MA, Cheresh DA. Differential av integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol 2003; 162:933-943.
50. Naik MU, Mousa SA, Parkos CA, Naik UP. Signaling through JAM-1 and αvβ3 is required for the angiogenic action of the bFGF:dissociation of the JAM-1 and αvβ3 complex. Blood 2003; 102:2108-2114.
51. Peddibhotla SSD, Brinkmann BF, Kummer D, Tuncay H, Nakayama M, Adams RH, Gerke V, Ebnet K. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling. Mol Biol Cell 2013; 24:933-944.
52. Nishimura T, Fukata Y, Kato K, Yamaguchi T, Matsuura Y, Kamiguchi H, Kaibuchi K. CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nat Cell Biol 2003; 5:819-826.
53. Rajendran D, Zhang Y, Berry DM, McGlade CJ. Regulation of Numb isoform expression by activated ERK signaling. Oncogene 2016; 1-12.
54. Dominguez M. Oncogenic programmes and Notch activity: an 'organized crime'? Sem Cell Develop Biol 2014; 28:78-85.
55. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 2001; 12:2699-710.
56. Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 2010; 31:192-200.
57. Rice J, Courter DL, Giachelli CM, Scatena M. Molecular mediators of alphavbeta3-induced endothelial cell survival. J Vasc Res 2006; 43:422-36.
58. Eyler CE, Wu Q, Yan K, MacSwords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, Sloan AE, Hjelmeland AB, Rich JN. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011; 146:53-56.
59. Wang D, Olman MA, Stewart J, Jr., Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee J, Weil RJ, Palmer CA, Gillespie GY, Liu WM, et al. Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS One 2011; 6:e19629.
60. Meijering E, Dzyubachyk O, Smal I. Methods for cell and particle tracking. Methods Enzymol 2012; 504:183-200.
61. Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I, Weller M. Integrin control of the transforming growth factor-beta pathway in glioblastoma. Brain 2013; 136:564-76.